NCT06663462

Brief Summary

This study compared EzPAP and noninvasive treatments of hypercapnic COPD attacks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 15, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 19, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 29, 2024

Completed
Last Updated

October 29, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

October 19, 2024

Last Update Submit

October 28, 2024

Conditions

Non Invasive Ventilation

Keywords

Chronic Obstructive Pulmonary disseaseNon-invasive ventilationEzPAP

Outcome Measures

Primary Outcomes (1)

  • Blood gas

    Carbon dioxide height, low bicarbonate and presence acidosis measure in the blood gas

    24 hours

Study Arms (2)

EzPAP group

EzPAP users

Non-invasive group

BPAP users

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

COPD disease

You may qualify if:

  • Clinical diagnosis of Chronic obstructive pulmonary disease Dyspnea

You may not qualify if:

  • Cardiac failure Dead

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oya Guven, MD

Kırklareli, Center, 39000, Turkey (Türkiye)

Location

Study Officials

  • Gökhan Karakurt, MD

    Kırklareli Training and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 19, 2024

First Posted

October 29, 2024

Study Start

December 15, 2022

Primary Completion

December 31, 2023

Study Completion

June 30, 2024

Last Updated

October 29, 2024

Record last verified: 2024-10

Locations

TU(1)